Načítá se...
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia
PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloid leukemia (AML) who are older or have comorbid conditions. Here, we examined outcomes after nonmyelo...
Uloženo v:
| Médium: | Článek |
|---|---|
| Jazyk: | en |
| Vydáno: |
American Society of Clinical Oncology
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2903320/ https://ncbi.nlm.nih.gov/pubmed/20439626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1460 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|